Year archive

Fujian Haixi Pharmaceuticals Co., Ltd. — 2026 filings

All 25 regulatory filings released by Fujian Haixi Pharmaceuticals Co., Ltd. (2637) in 2026, sourced directly from the official regulator.

25 Filings

2026 Period

2026 filings (25)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026 Regulatory Filings	2026-06-04	English
Rules of Procedure for Meeting of the Board of Directors Governance Information	2026-05-27	English
Rules of Procedure for Shareholders' Meeting Governance Information	2026-05-27	English
Articles of Association Governance Information	2026-05-27	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2026-05-27	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 27 MAY 2026, CHANGE OF DIRECTORS, ELECTION OF CHAIRMAN AND APPOINTMENT OF SENIOR MANAGEMENT, CHANGE IN COMPOSITION OF BOARD COMMITTEE AND ABOLISHMENT Declaration of Voting Results & Voting Rights Announcements	2026-05-27	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 Regulatory Filings	2026-05-07	English
PROXY FORM FOR THE ANNUAL GENERAL MEETING AGM Information	2026-04-30	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2026-04-30	English
2025 AGM Circular AGM Information	2026-04-30	English
2025 Environmental, Social and Governance Report Environmental & Social Information	2026-04-29	English
ANNUAL REPORT 2025 Regulatory Filings	2026-04-29	English
PROPOSED ADOPTION OF THE SHARE INCENTIVE SCHEME Share Issue/Capital Change	2026-04-29	English
Notification Letter to Non-registered Holders of H Shares and Request Form - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2026-04-28	English
Notification Letter to Registered H Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2026-04-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 Regulatory Filings	2026-04-08	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025 Annual Report FY 2025	2026-03-30	English
VOLUNTARY ANNOUNCEMENT - ORAL wAMD DRUG PROJECT HXP056 COMPLETED ENROLLMENT FOR PHASE I CLINICAL STUDY AND INITIATED PHASE 2 STUDY Regulatory Filings	2026-03-24	English
DATE OF MEETING OF THE BOARD OF DIRECTORS Report Publication Announcement	2026-03-10	English
CHANGE OF JOINT COMPANY SECRETARY, AUTHORISED REPRESENTATIVES AND PROCESS AGENT AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES Board/Management Information	2026-03-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 Regulatory Filings	2026-03-05	English
APPOINTMENT OF SENIOR MANAGEMENT Board/Management Information	2026-03-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Regulatory Filings	2026-02-05	English
DISCLOSEABLE TRANSACTION SUBSCRIPTIONS OF FINANCIAL PRODUCTS Capital/Financing Update	2026-02-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 Share Issue/Capital Change	2026-01-07	English